Viking Therapeutics, Inc.
VKTXW
VKTXW was delisted on the 8th of April, 2021.
2 hedge funds and large institutions have $274K invested in Viking Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
188% more capital invested
Capital invested by funds: $95K → $274K (+$179K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $204K | -$1.5K | -3,500 | -1% |
|
|
PWAM
2
Park West Asset Management
San Francisco,
California
| $70K | – | – | – |
|
VKTXW Hedge Fund Activity: Q3 2017 in Review
2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q3 2017, worth a combined $274K — up 188% from $95K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of VKTXW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, cutting an estimated $1.5K.
- 2 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q3 2017, down from 3 in Q2 2017.
- Funds reported $274K of Viking Therapeutics, Inc. stock for Q3 2017, up 188% quarter-over-quarter.
- 0 funds opened new Viking Therapeutics, Inc. positions in Q3 2017 and 1 closed out, a net change of -1 holder.
- The largest Viking Therapeutics, Inc. seller in Q3 2017 was Susquehanna International Group, an estimated $1.5K sold.
Based on aggregated 13F filings for Q3 2017.